Economic evaluation of brief psychodynamic interpersonal therapy in patients with multisomatoform disorder

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Chernyak, Nadja ^a,b   Sattel, Heribert ^c   Scheer, Marsel ^b   Baechle, Christina ^b   Kruse, Johannes ^a   Henningsen, Peter ^c   Icks, Andrea ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b LEIBNIZ CENTER FOR DIABETES RESEARCH AT HEINRICH HEINE UNIVERSITY DÜSSELDORF   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; ECONOMIC EVALUATION; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; HEALTH INSURANCE; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; MULTISOMATOFORM DISORDER; OUTPATIENT CARE; PSYCHODYNAMIC INTERPERSONAL THERAPY; PSYCHODYNAMIC PSYCHOTHERAPY; QUALITY ADJUSTED LIFE YEAR; RANDOMIZED CONTROLLED TRIAL; SOMATOFORM DISORDER; ADOLESCENT; CLINICAL TRIAL; COST BENEFIT ANALYSIS; ECONOMICS; MIDDLE AGED; OUTCOME ASSESSMENT; OUTPATIENT; PROCEDURES; PSYCHOLOGY; PSYCHOTHERAPY; QUALITY OF LIFE; QUESTIONNAIRE; SOMATOFORM DISORDERS; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; COST-BENEFIT ANALYSIS; HUMANS; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); OUTPATIENTS; PSYCHOTHERAPY, BRIEF; QUALITY OF LIFE; QUALITY-ADJUSTED LIFE YEARS; QUESTIONNAIRES; SOMATOFORM DISORDERS; YOUNG ADULT;

EID: 84899795300     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0083894     Document Type: Article

References (13)

1. Henningsen P, Zipfel S, Herzog W (2007) Management of functional somatic syndromes. Lancet 369: 946-55. (Pubitemid 46400832)
2. Jackson JL, Kroenke K (2008) Prevalence, impact, and prognosis of multisomatoform disorder in primary care: a 5-year follow-up study. Psychosom Med 70(4): 430-4
3. Sattel H, Lahmann C, Gündel H, Guthrie E, Kruse J, et al (2012) Brief psychodynamic interpersonal psychotherapy for patients with multisomatoform disorder: randomised controlled trial. Br J Psychiatry 200(1): 60-7.
4. Kroenke K, Spitzer RL, deGruy FV 3rd, Hahn SR, Linzer M, et al (1997) Multisomatoform disorder. An alternative to undifferentiated somatoform disorder for the somatizing patient in primary care. Arch Gen Psychiatry 54: 352-8. (Pubitemid 27171921)
5. Brazier J (1995) The Short-Form 36 (SF-36) Health Survey and its use in pharmacoeconomic evaluation. Pharmacoeconomics 7(5): 403-15
6. Gold MR, Siegel JE, Russell LB, Weinstein MC (Eds.) (1996) Cost-effectiveness in health and medicine. N Y: Oxford University Press.
7. Drummond MF, Sculpher MJ, Torrance GW, O'Brien B, Stoddart GL (2005) Methods for the Economic Evaluation of Health Care Programmes. Oxford: Oxford University Press
8. Brazier J, Roberts J, Deverill M (2002) The estimation of a preference-based measure of health from the SF-36. J Health Econ 21: 271-92. (Pubitemid 34143147)
9. Fenwick E, Claxton K, Sculpher M (2001) Representing uncertainty: the role of cost-effectiveness acceptability curves. Health Econ 10: 779-87. (Pubitemid 34041389)
10. Van Buuren S (2007) Multiple imputation of discrete and continuous data by fully conditional specification. Statistical Methods in Medical Research 16 (3): 219-242.
11. Mutebi A, Brazier JE, Walters SJ (2011) A comparison of the discriminative and evaluative properties of the SF-36 and the SF-6D index. Qual Life Res 20(9): 1477-86.
12. Claxton K (1999) The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies. J Health Econ 18: 341-64.
13. Briggs A, Clark T, Wolstenholme J, Clarke P (2003) Missing... presumed at random: cost-analysis of incomplete data. Health Econ 12(5): 377-92. (Pubitemid 36603549)